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Abstract
HIV-1 infection can be associated with neuropsychological (NP) deficits ranging from subtle to severe. The purpose
of this study was to evaluate the functional, or “real-world” impact of HIV-associated NP impairment in a group of
267 HIV-infected participants. All participants received comprehensive NP, neuromedical, and standardized
functional evaluations that included laboratory measures of shopping, cooking, financial management, medication
management and vocational abilities. Compared to NP-normal participants, those with NP impairment performed
significantly worse on all laboratory measures of everyday functioning. Multivariate analyses revealed that the NP
ability domains of Abstraction0Executive Function, Learning, Attention0Working Memory and Verbal abilities most
strongly and consistently predicted failures on the functional battery. Both NP impairment and impairment on the
functional battery were significantly associated with subjective experiences of cognitive difficulties, as well as
unemployment and increased dependence in activities of daily living; multivariate prediction models that also
considered depressed mood and biological measures of disease progression revealed that impairment on the
functional battery and depression were the only unique predictors of all three indicators of “real-world” functioning.
The current results add to growing evidence concerning the clinical significance of HIV-associated NP impairment.
Objective, laboratory based functional measures, such as those used here, may compliment NP testing in future
studies directed at understanding the impact on life quality of central nervous system disorders and their treatments.
Finally, there is a need for additional research investigating the apparently independent effect of depression on level
of everyday functioning in HIV infected persons. (JINS, 2004, 10, 317–331.)
Keywords: HIV, Activities of daily living, Everyday functioning, Cognition

in white matter volumes, and a spotty pattern of mild NP
impairments, with increasing structural abnormalities and
NP impairment as HIV disease state advances (Heaton et al.,
1995; Jernigan et al., 1993; Stout et al., 1998).
A common difficulty in establishing HIV-related neurocognitive diagnoses, either for research or clinical purposes, is obtaining reliable and valid data concerning the
patients’ levels of competence in everyday functioning.
Changes in everyday functioning are required for the diagnosis of HIV-related syndromic neurobehavioral disorders
such as minor cognitive motor disorders (MCMD) and HIV
associated dementia (HAD; American Academy of Neurology AIDS Task Force, 1991). However, most available instruments for detecting these changes, such as self-report

INTRODUCTION
HIV-infection can be associated with CNS involvement and
changes in neurobehavioral status, particularly in advanced
stages of the illness (Bornstein et al., 1992; Grant et al.,
1987; Heaton et al., 1995; Stern et al., 1991). Neuroimaging and neuropsychological (NP) studies suggest initial preferential involvement of frontostriatal circuitries, reduction
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questionnaires and checklists (Lawton et al., 1969), or even
more direct and objective measures of functional ability
such as the Direct Assessment of Functional Status (DAFS;
Lowenstein et al., 1995), are designed for elderly subjects
with dementing disorders (e.g., dementia of the Alzheimer’s type). Although useful in these populations, such
instruments have proven insensitive to the mild NP impairments observed in the generally younger HIV-infected
(HIV1) adult population.
At present, the few available studies concerning functional impact of HIV-related NP deficits suggest that these
deficits are associated with impaired driving ability, worse
performance on standardized work samples, increased unemployment and complaints of problems in vocational functioning and everyday living (Albert et al., 1995; Benedict
et al., 2000; Heaton et al., 1996; Mapou et al., 1993; Marcotte et al., 1999; Stern et al., 1991). Of particular importance to HIV1 patients is the ability to effectively manage
their antiretroviral medications. Preliminary studies suggest that HIV1 participants with impairments in memory,
executive function, and psychomotor functioning can demonstrate significant difficulties with performance on structured tasks of medication management ability, as well as
adherence to medication regimens in everyday life (Albert
et al., 1999; Hinkin et al., 2002).
The above studies consistently suggest that HIV-associated
cognitive impairment can interfere with everyday functioning. Nevertheless, traditional NP tests used to identify such
impairments have, at best, limited face validity as measures
of everyday life requirements. It may well be that standardized versions of essential everyday tasks would also be sensitive to disease related changes in cognitive abilities, yet
more readily interpretable with respect to questions about
patients’ everyday functioning. The field remains hampered by the lack of a sensitive, comprehensive functional
battery for use with HIV patients (and those with other
disorders that present with a pattern of relatively mild NP
impairments), in order to make empirically validated predictions of functional ability. As was pointed out in one
recent study which used questionnaires and gross measures
of functional ability, more refined measures are needed in
order to better evaluate the clinical or real-world significance of HIV treatment effects (Schiffito et al., 2001).
The purpose of this study was to extend prior investigations of the clinical significance of NP impairment in a
large cohort of HIV-infected individuals, by first evaluating
the psychometric properties of newly developed functional
measures, and then assessing the concurrent validity of a
relatively comprehensive functional battery by examining
the cross-sectional relationships both with NP impairments
and important aspects of everyday functioning. Areas of
focus included instrumental activities of daily living
(IADLs), required for living independently, as well as vocational ability. The former activities are especially relevant for persons in more advanced disease states and0or
more severe NP impairment; vocational abilities are more
relevant to HIV1 persons with minimal to mild NP impair-
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ment who are well enough to work. It was hypothesized
that (1) compared to NP-normal HIV1 participants, NPimpaired subjects would perform worse on laboratory measures of everyday functioning; and (2) impairments on NP
and laboratory measures would predict increased problems
in everyday functioning outside of the laboratory (i.e., perceived cognitive difficulties, need for more assistance in
managing daily living tasks, more “downward drift” in the
kinds of jobs they were performing, and higher unemployment rates). Although most everyday functioning tasks involve numerous cognitive abilities, and therefore may be
disrupted by a variety of cognitive impairments, exploratory multivariate analyses will be used to determine which
NP ability deficits most strongly predict failures in the functional test battery. Finally, receiver operating characteristic
(ROC) curve analyses and likelihood ratios will be used to
demonstrate the probabilities of increased dependence in
everyday living, based upon performance on the laboratorybased functional battery.

METHODS
Research Participants
Table 1 provides a summary of demographic, immune status and diagnostic information for the total sample of 267
HIV-infected adults who participated in this study. Participants were recruited by the HIV Neurobehavioral Research
Center (HNRC), an NIMH-funded center for the study of
the prevalence, features, course and pathogenesis of HIV
involvement in the central nervous system (CNS). As part
of their participation in the HNRC, participants completed
comprehensive neuromedical and NP assessments. In addition, all participants underwent a urine toxicology screen
on the NP visit day, and all participants were negative for
illicit substance use (i.e., non-prescribed stimulants, opiates, benzodiazepines, barbiturates, sedatives, etc.). Poten-

Table 1. Demographic and disease characteristics
of 267 HIV-infected participants
Demographic variable

M or P

SD

Age
Education
CD4 Cell Count
Percent Male
Ethnicity
White
African American
Latino
Other
Disease Stage
CDC A
CDC B
CDC C
AIDS

39.32
13.29
356.5
84%

7.52
2.4
267
—

62%
24%
10%
4%

—
—
—
—

22%
44%
34%
58%

—
—
—
—
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tial participants were excluded based on the presence of
cognitive impairment that could be attributed to factors other
than HIV illness (e.g., brain trauma with loss of consciousness greater than 30 min, other neuromedical comorbidities,
active substance abuse or dependence within the last 30 days,
or evidence of learning disabilities or schizophrenia).
The cohort included both individuals who were medically asymptomatic, as well as those at more advanced disease stages. Participants were classified using the Centers
for Disease Control (1992) HIV Disease Classification, a
system that categorizes HIV-infected adolescents and adults
based on clinical conditions associated with HIV infection
and CD4 T-lymphocyte count. Details regarding CDC stage
and AIDS status are also provided in Table 1.
Plasma HIV RNA levels were available for 259 of our
participants. Of these, 80 (30.9%) had viral loads in the
undetectable range (# log 2.6). For the remaining 179 participants with detectable HIV viral load, their mean plasma
HIV viral load level was log 4.39 (SD 5 0.95). Seventy-two
percent (n 5 194) of the cohort was on some form of an
antiretroviral medication regimen as prescribed by their respective primary care providers.

Procedure
Neuromedical evaluation
All participants underwent comprehensive neuromedical
evaluations, which included: completion of structured clinical data gathering forms; medical and medication use history; neurological and general physical examinations; and
laboratory studies including CD4 lymphocyte counts, and
routine hematology and chemistry. HIV serological status
was determined by enzyme linked immunosorbent assays
(ELISA) with Western Blot confirmation.

Mood evaluation
The presence of depressive symptoms was evaluated with
the Beck Depression Inventory (BDI; Beck, 1987), which
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is a 21-item questionnaire regarding current mood. On average, participants reported a mild level of depressive symptoms as indicated by the BDI total score (M 5 10.6, SD 5
10.4), with 28% reporting depressive symptoms at a level
that is generally considered to be clinically significant
(greater than or equal to 15).

Neuropsychological evaluation
All participants completed a detailed neuropsychological
test battery administered by trained psychometrists. Table 2
summarizes the 4-hr battery, which consists of measures
assessing the following seven ability domains: verbal skills,
attention0working memory, speed of information processing, learning, memory (delayed recall), abstraction0executive
functioning, and motor skills.
Consistent with the recommendations of the NIMH Working Group on Neuropsychological Assessment Approaches
in HIV Infection (Butters et al., 1990), each participant’s
NP test protocol was rated by a senior neuropsychologist
(R.K.H.) blinded to HIV serostatus and the participant’s
performance on the functional measures. The rater was able
to remain blinded to HIV serostatus because the charts from
the current study did not contain this information and were
randomly mixed with those of other studies in which HIV
seronegatives were also included. Clinical ratings were determined after converting raw scores on the tests to age-,
education- and gender-corrected standard scores (T-scores)
using published procedures based upon large normative data
sets (Diehr et al., 1998; Gladsjo et al., 1999; Heaton, 1992;
Heaton et al., 1991). Clinical ratings of NP function were
assigned for each of the seven major ability areas listed in
Table 2, using the following 9-point scale: 1 5 above average functioning; 2 5 average; 3 5 below average; 4 5
borderline0atypical; 5 5 definite mild impairment; 6 5 mild
to moderate impairment; 7 5 moderate impairment; 8 5
moderate to severe impairment; 9 5 severe impairment.
Participants were also assigned a global NP clinical rating
using the same scale, with a global rating of 5 or above

Table 2. Neuropsychological test battery arranged by the seven major ability areas
Verbal
Boston Naming Test (# correct)1
Thurstone Word Fluency (Correct)1
Category Fluency (Animals) 2
Information Processing Speed
WAIS–R Digit Symbol 3
Trail Making Test (Part A)1
WAIS–R Block Design 3
Motor
Grooved Pegboard Time (dominant hand)1
Grooved Pegboard Time (non-dominant hand)1
Finger Tapping (dominant hand)1
Finger Tapping (non-dominant hand)1

Abstraction0Executive Functioning
Category Test (# errors)1
Trail Making Test (Part B)1
Attention0Working Memory
WAIS–R Digit Span 3
WAIS–R Arithmetic 3
PASAT Total Correct 1
Learning
Story Learning (points0trials)1
Figure Learning (points0trials)1
Delayed Recall
Story Memory 1
Figure Memory 1

Note. Normative data taken from the following sources indicated by superscript number: 1 Heaton et al.,
1991; 2 Gladsjo et al., 1999; 3 Wechsler, 1981.
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indicating abnormal NP functioning; a global rating in this
range required a mild or higher impairment rating on at
least two of the seven ability areas (i.e., a single, isolated
ability deficit would not qualify for a global rating with the
impaired range). The ratings procedure utilized in this study
has undergone extensive evaluation, and inter-rater reliability has been found to be excellent. The rationale, nature,
reliability and validity of these ratings have been described
in detail elsewhere (Heaton et al., 1981, 1994a, 1994b, 1995).

Functional evaluation
In order to assess the functional relevance of NP impairment, two methodologies were used: (1) objective,
laboratory-based measures of capacity to perform tasks that
are important in everyday living, and (2) reports of everyday functioning outside of the laboratory (Manifest Functioning). The latter reports ranged from subjective ratings
of abilities0disabilities to more readily observable and verifiable facts such as employment status, and assistance received by others in specific aspects of daily living (e.g.,
financial management). All measures were administered by
trained psychometrists. The neuropsychological and functional batteries were administered in a fixed order (functional battery order: Shopping, Financial Skills, Advanced
Finances, Medication Management Test–Revised, Cooking, Vocational Assessment).
In the Laboratory assessment, objective levels of IADL
functioning were measured using previously established tests,
as well as newly created everyday functioning tasks. The
Financial Skills (e.g., calculating currency, balancing a
checkbook), and Shopping (e.g., selecting items from a previously presented grocery list) measures from the Direct
Assessment of Functional Status instrument (DAFS; Lowenstein & Bates, 1992) were selected as subtests that were
expected to be sensitive to cognitive impairment in HIV
disease. The DAFS was designed for use with demented,
elderly individuals, and the additional measures from that
instrument were found to be inappropriate for our population. (For a more detailed description of these DAFS measures, please refer to Lowenstein & Bates, 1992.) Therefore,
new functional measures expected to be both sensitive to
the mild NP problems found in HIV, and relevant to the
daily functioning of individuals living with HIV, were
needed. Two new functional measures that assess areas with
which participants in our study commonly reported having
difficulty include Advanced Finances and Cooking. These
measures are briefly described below.
In Advanced Finances, individuals are asked to pay fictitious bills and manage a fictitious checkbook. They are
provided with blank checks, a checkbook register, a check
to deposit, deposit slips, three bills to pay and a calculator.
They are required to pay each bill and determine their checkbook balance. The most difficult part of this task requires
individuals to pay as much of their credit card bill as they
can while assuring that they will have $100 remaining in
their checking account for other needs. Points are awarded
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for correctly paying each bill, writing checks, filling out the
deposit slip, balancing the register, and making sure that
there is a final balance of at least $100. The task takes
approximately 10 minutes to administer and there are 13
possible points. The more basic DAFS Finances and our
Advanced Finances tasks were merged into one measure,
the Finances task, with a total of 35 points possible.
Medication management ability was evaluated with a revised version of the Medication Management Test (MMT;
Albert et al., 1999). The original version of this measure
included a “pill dispensing” component and a “medication
inference” component. In the former component, participants are observed and scored with respect to their ability
to dispense one day’s dosage and follow a fictitious prescription regimen, which includes five different mock medications that would be consistent with many of the current
therapies that are used in the treatment of HIV. Pill bottles
are provided with realistic instructions on standardized labels. As part of this task, participants must transfer the
correct number of pills from the pill bottles to a medication
organizer designed to hold a 1-week’s supply of medication. Participants are scored on the percentage of prescriptions that they correctly place in the organizer (i.e., 0% 5
all 5 incorrect to 100% 5 all 5 correct.
The “medication inference” component of the original
MMT includes 15 items, which require participants to answer questions regarding the five mock medications, as well
as one over-the-counter medication insert. Items include
information pertaining to how long prescriptions will last,
dosage information, and following special instructions, such
as taking a medication with or without food. On average,
the original MMT takes 15–25 min to administer.
In our modified version, the MMT–Revised (MMT–R)
includes only those items which were found to be the most
reliable and valid based on pilot work with our participant
population, and was criterion-referenced via guidance from
an HNRC infectious disease physician and AIDS expert
(JAM). The MMT–R retains both components of the original MMT; however, pill dispensing utilized only three of
the original five mock medications, and the medication inference component includes seven of the original 15 items.
In addition, the inference items are now presented in ascending order of difficulty, some items have been slightly
reworded to make them easier to comprehend, and the medication insert was changed in order to provide the information in a more straightforward manner (see the Appendix
for the insert). The MMT–R takes approximately 10 min to
administer, and 10 points are possible. The MMT–R task
was added to the functional battery after the beginning of
the study; therefore, 74 participants did not complete this
task.
In the Cooking task, individuals are required to follow
recipes and coordinate a meal, and also involve measuring,
stirring, and wrapping items. Participants are provided with
two recipe cards, one with three cooking steps (pasta) and
another that requires only one cooking step (heating bread).
The most difficult part of this task asks participants to de-
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termine the order and timing with which to cook the items
so that both items are completed at approximately the same
time. Points are awarded for following instructions, as well
as completing the items at the same time. The task takes
approximately 8 min to administer and there are 30 possible points.
In addition to the above IADL tasks, we utilized information gathered from work histories and a series of objective, criterion-referenced vocational tests as part of the
Vocational Assessment. Together, these two types of information can be used to determine whether participants evidence poorer performance on measures of current vocational
functioning than would be expected based upon their prior
work histories (Heaton et al., 1996).
The U. S. Department of Labor lists 12,855 jobs in the
Dictionary of Occupational Titles (DOT; US Department
of Labor, 1991a). Each job is assigned a DOT “Worker
Qualifications Profile” in which it is rated with regard to
the specific levels of all abilities that are required to perform it. These ability requirements include two categories
applicable to this study: (1) General Educational Development (GED) is comprised of Reasoning, Mathematics, and
Language; and (2) Aptitudes are the more specific abilities
required by the job. They include Learning, Verbal, Numerical, Spatial, Form Perception, Clerical Perception, Motor
Coordination, Finger Dexterity, Manual Dexterity, EyeHand-Foot Coordination and Color Discrimination.
There are six functional levels for each of the GED abilities and five functional levels for the specific Aptitudes.
The functional levels were designed by the Department of
Labor in order to rank specific abilities within each GED
domain and Aptitude. The Department of Labor then determined the number of jobs within the US economy that require each level for each ability. In general, in the middle
functional levels (where most people perform), thousands
of jobs are involved. Thus, if a worker’s ability drops one
level in the middle range (e.g., due to NP impairment), this
can suggest that there are many jobs he0she can no longer
perform. For a complete explanation, see the Revised Handbook for Analyzing Jobs (US Department of Labor, 1991b)
and the Dictionary of Occupational Titles (US Department
of Labor, 1991a). One limitation of vocational assessments
is that they do not account for experience, so that a person
can perform poorly on a novel work sample but perform
adequately on job tasks with which she or he has had years
of experience. Therefore, experience might reduce the impact on job performance of acquired NP impairment but
still result in deficits when measured with standardized vocational tests (Salthouse, 1990, 1994).
Participants completed standardized work samples
(MESA SF2) and the next generation COMPASS programs
(Valpar International Corporation, 1986, 1992). These batteries consist of multi-modal, criterion-referenced instruments designed to establish participant skill levels in areas
related to vocational functioning. The battery takes approximately 1 hr and includes computerized subtests and noncomputerized mechanical tasks that correspond to the
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previously mentioned DOT Job levels. The computerized
tests are comprised of Vocabulary, Reading, Spelling, Mathematics, Language Development (Editing), Problem Solving, Short-term Visual Memory, Shape Discrimination, Size
Discrimination, and Placing and Tracking. The mechanical
tasks involve Alignment and Driving, Machine Tending and
Wiring. Raw scores from these tests are automatically converted into ability levels for each of the DOT classifications
using the commercial software accompanying the MESA
SF2 and COMPASS. A detailed explanation of test development for the MESA and COMPASS is beyond the scope
of this paper (see Valpar International Corporation, 1986,
1992). Briefly, an expert panel assigned to each test item a
corresponding ability level. Once the examinee commits a
certain number of errors on items at a particular ability
level, the subtest is discontinued with the resulting score
assigned as the highest ability level before discontinuation.
The expert panel also determined minimum ability levels
on one or several subtests in order for an examinee to qualify for a functional level within Aptitudes or GED abilities.
For example, a person’s Spatial Aptitude level depends on
his or her obtaining certain ability level scores on the Alignment and Driving, Shape, and Size subtests. All scores on
the subtests and on the GED and Aptitudes are completely
criterion referenced and are designed for classification according to DOT categories. They are therefore distinct from
typical neuropsychological tests measuring similar constructs in that they are not based on normative data but on a
specific criterion, and the outcome scores are designed to
conform to DOT profile scores rather than standardized
scores that might correct for one or more demographic variables. For the purposes of this paper, the functional levels
for the Aptitudes and GED abilities were summed in order
to calculate a Work Assessment Total Score to provide an
overall index of vocational ability (Heaton et al., 1996).
Manifest Functioning is defined as self-report of everyday functioning outside of the laboratory. Participants were
asked to complete two questionnaires regarding their current level of everyday functioning. The Patient’s Assessment of Own Functioning Inventory (PAOFI; Chelune et al.,
1986) is a 41-item questionnaire in which the participant
reports the frequency with which he0she has difficulties
with memory, language and communication, use of his0her
hands, sensory-perception, higher level cognitive and intellectual functions, work and recreation. This instrument focuses on cognitive symptoms, and is used by HNRC
clinicians in their determination of an AAN diagnosis of
syndromic versus subsyndromic NP impairment (i.e., “subsyndromic” impairment does not appear to interfere with
the patient’s everyday functioning).
Most of the participants (n 5 251) also completed a modified version of the Lawton and Brody (1969) IADL scale,
which includes 13 items detailing the degree to which they
independently function in the areas of Financial Management, Home Repair, Medication Management, Laundry,
Transportation, Grocery Shopping, Comprehension of
Reading0TV Materials, Shopping, Housekeeping (Clean-
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ing), Cooking, Bathing, Dressing, and Telephone Use. For
each activity the participant separately rates his0her current
level of independence and highest previous level of independence. The total score is the total number of activities
for which there is currently a need for increased assistance
(ranging from minimal to complete assistance), with a range
of zero (no change) to 13 (increased dependence in all
activities). By examining the distributions of 168 NPnormal participants on this scale, it was determined that
increased dependence on two or more of the 13 areas of
functioning is relatively rare in this population (i.e., it
occurred in fewer than 15% of cases). Therefore, we used
a cut-off score of 2 as our criterion for overall IADL
dependence.

Statistical analyses
Using the entire sample, Cronbach’s alpha reliability coefficients were calculated for the three newly developed or
revised functional measures, in order to assess the internal
reliability of these instruments. Participants were then organized into two groups based on their global NP ratings, as
NP-normal (ratings of 1– 4) and NP-impaired (ratings of
5–9). To compare initial characteristics and performance
on the functional assessment between groups, chi-square
test for proportions, t tests, and analysis of variance
(ANOVA) were used. Correlational analyses assessed the
relationships between NP functioning (based on clinical ratings) and performance on certain laboratory functional measures. Nominal logistic regressions were used to determine
which NP ability deficits were most predictive of failures in
the laboratory-based functional measures. Linear and logistic regression analyses also were performed in order to evaluate unique contributions of NP status, the Functional Deficit
Score (see below), medical variables and depressed mood
(BDI) as potential predictors of three functional outcome
measures: cognitive complaints, IADL dependence, and employment status. Bonferroni corrections were applied to address alpha inflation due to multiple comparisons. As
mentioned above, ROC curve analyses and likelihood ratios will be used to evaluate the probabilities of increased
dependence in everyday living, based on performance on
our functional test battery. Details of these methods are
beyond the scope of the current paper, but can be readily
found in the literature (e.g., Woods et al., 2003; Zweig &
Campbell, 1993).
A Functional Deficit Score (FDS), based upon all of the
functional measures, was formulated to reflect overall impairment on the laboratory based functional battery. Similar
to procedures previously used to characterize NP impairment (Heaton et al., 1995), deficit scores (0 5 normal to
5 5 severe impairment), were derived for each of the functional measures based on the performance and percentile
ranks of 168 NP-normal participants on the functional assessment. As with classifications of T-score ranges in NP
tests (Heaton et al., 1991, 1992), a cut-off of 1 SD below
the mean of normals defines the range most likely to reflect
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normal performance, and 0.5 SD-wide ranges lower than
that define mild (deficit score 5 1), mild-to-moderate (2),
moderate (3), moderate-to-severe (4) and severe (5) impairment. After these cut-offs were derived, the research team
qualitatively reviewed the functional protocols of participants who obtained deficit scores greater than zero. For
each functional measure it was determined that performances statistically classified as impaired actually did reflect inadequate performance of the IADL task in question
(e.g., serious errors in medication management, failure to
produce a “palatable” meal, failures in paying bills and0or
allowing for specified financial needs). Thus, functional
tests or FDS performances above the 15th percentile of the
normative sample were considered normal (deficit score 5 0),
and increasingly worse test raw scores were assigned deficit scores between 1 and 5. A separate 0–5 deficit score was
assigned for MMT–R, Cooking, Finances, DAFS Shopping, and Work Assessment. These individual deficit scores
were then averaged to create the FDS summary score. The
FDS can be considered as a continuous variable or, again
using the 15% cutoff from the 168 NP-normal participants,
it can be used to classify participants as impaired (FDS .
0.50) or normal (FDS , 0.51) on the functional battery.
Since the MMT–R task was added to the functional battery following the inception of the study, 74 study participants did not complete this measure. Therefore, a prorated
FDS was calculated for all participants who did not complete the MMT–R task. Descriptive, chi-square, and correlational analyses revealed that this prorated FDS could be
used without a significant loss of validity to the measure.
For those participants with both an FDS and Prorated FDS
(n 5 193), the means and standard deviations of the two
measures were virtually the same (FDS: M 5 0.56, SD 5
0.75; prorated FDS: M 5 0.52, SD 5 0.73); there was overall agreement in rate of functional impairment between the
measures (specificity 5 92%; sensitivity 5 100%; classification accuracy 5 94%); and the two measures were very
strongly correlated with one another (r 5 .97, p , .00001).
Therefore, for the following statistical analyses, the prorated FDS will be used as the FDS for those 74 participants
who did not complete the MMT–R task.

RESULTS
Among the 267 HIV1 study participants, 168 were classified as NP-normal and 99 as NP-impaired; level of impairment was rated as mild in 60 participants, mild-to-moderate
in 34, and moderate in 5 participants. The most prevalent
deficits among the NP-impaired individuals were in ability
domains of Learning (68%), Abstraction0Executive functioning (54%), Attention0Working Memory (53%), and Motor Functioning (47%). The least prevalent ability deficits
for the NP-impaired group were Speed of Information Processing (36%), Verbal Functioning (27%), and Delayed Recall (25%). NP-impaired individuals averaged somewhat
less education, and were more immunosupressed, and more
likely to be unemployed and non-White (see Table 3).
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Table 3. Comparison of NP-normal and NP-impaired groups
on demographic and disease variables
NP-Normal
Variable

NP-Impaired

M or P SD M or P SD

t0x 2

p

Age
39.3
7.5 39.4
6.5 20.08 .9
Education
13.6
2.4 12.9
2.3 2.4
.02
CD4
386
285 305
224
2.6
.01
Percent male
85.7 —
79.8 —
1.5
.2
Ethnicity (percent)
White
70.8 —
45.5 — 16.8 ,.001
African American 17
—
37
—
—
—
Hispanic
9
—
11
—
—
—
Other
4
—
6
—
—
—
Percent AIDS
56.0 —
61.6 —
0.8
.4
Percent CD4 , 200 27.4 —
38.4 —
3.5
.06
Percent employed
36.8 —
11.6 — 21.0 ,.001
Note. NP 5 Neuropsychologically. n 5 168 for NP-Normal, n 5 99 for
NP-Impaired.

Reliability and Distribution Characteristics
of New/Revised Functional Measures
Table 4 summarizes the results of reliability analyses and
the range of scores for each of our newly developed or
modified functional measures. The Cronbach’s alpha coefficients for the new measures reveal generally adequate internal reliability (.66 to .82). Considering that these are
everyday tasks that most adults are expected to perform, it
is not surprising that a sizeable minority of HIV1 participants performed at ceiling. Nevertheless, the score ranges
in Table 4 also show that the total group evidenced considerable variability in performance on these measures.

NP Status and Laboratory Measures
of IADLs
Table 5 presents the results of one-way ANOVAs, effect
sizes and confidence intervals for comparisons of the NP-

Table 4. Participant performance characteristics and internal
reliability of newly developed0modified functional measures
Variable
N
Possible range
Actual range
M
SD
Test reliability (Cronbach’s a)
Percent at ceiling
Entire sample
NP-normal
NP-impaired

Cooking

Finances

MMT–R

267
0–30
11–30
26.6
4.4
.66

266
0–35
17–35
32.5
3.0
.82

193
0–10
1–10
8.2
2.1
.72

42
51
25

13
15
8

43
61
16

Note. MMT–R 5 Medication Management Test–Revised. NP 5 Neuropsychologically.

normal and NP-impaired groups on the FDS and the individual functional ability measures. As the table indicates,
NP-impaired participants performed significantly worse on
the FDS and each of the functional measures, compared to
NP-normal participants (all ps , .0001). Effect sizes for
the FDS and all individual functional measures were large,
ranging from 0.71 (Cooking) to 1.42 (FDS). The FDS and
Work Assessment had the largest effect sizes, and the confidence intervals indicate that they were significantly larger
than those found for two of the other functional measures
(e.g., Cooking and Shopping).
As Figure 1 illustrates, NP-impaired participants demonstrated a significantly higher rate of global functional impairment (based on the FDS) compared to NP-normal
participants [67% vs. 15%; x 2 (1) 5 73.10, p , .0001], and
NP-impaired participants were also significantly more likely
to fail on every domain of functional ability, including Work
Assessment [x 2 (1) 5 62.40, p , .0001], Finances [x 2 (1)
46.92, p , .0001], Medication Management [x 2 (1) 32.87,
p , .0001], Cooking [x 2 (1) 5 24.82, p , .0001], and Shopping [x 2 (1) 12.86, p , .0003], with the rates of functional
impairment being highest in the areas of Work, Finances,
and Medication Management. All comparisons remained
statistically significant following Bonferroni correction ( p 5
.006).
It is possible that some of the above mentioned findings
could be confounded by participants’ lack of familiarity
with certain skills (e.g., using a checkbook and cooking).
However, post hoc analyses revealed that lack of familiarity was a rare occurrence, at least with regard to use of a
checkbook and cooking. A majority (248) of the participants were asked whether they currently use a checking
account, and for those who did not currently have a checking account, they were asked if they had previously had a
checking account. Seventy-four percent (n 5 182) of the
sample currently used a checkbook, and of those 66 participants who did not currently use a checkbook, the majority
(n 5 55) had independently used a checkbook in the past.
Therefore, a total of 237 of the 248 participants (96%) with
available data had currently or previously used a checkbook in their daily lives. Of the 11 participants who had
never used a checkbook, 10 of these were NP-impaired and
were less educated than participants who had experience
with using checkbooks [years of education M 5 11.36, SD 5
1.75 vs. M 5 13.88, SD 5 2.41; t(246) 5 22.75, p , .01].
With regard to the Cooking task, 264 participants were asked
whether they currently or had previously cooked independently. At the time of the assessment, 83% of the participants (n 5 219) reported that they currently cooked, and of
the 45 participants who reported that they did not currently
cook, most (n 5 33) reported that they had cooked previously. Thus, 95% of this large subsample had current or
previous cooking experience.
Post-hoc analyses were also conducted to evaluate whether
there were any differences in overall functional ability (FDS)
based on demographic or disease-related variables in the
NP-normal group. Bivariate analyses revealed that, among
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Table 5. Comparisons of Neuropsychologically (NP) normal and NP-impaired
HIV1 groups on the Functional Deficit Score a (FDS) and individual
functional measures
NP-Normal
Measure
FDS*
Work Assessment
MMT–R
Finances
Shopping
Cooking

NP-Impaired

M

SD

M

SD

F**

Effect
size

Confidence
interval

0.22
36.86
9.08
33.39
16.48
27.73

0.37
6.26
1.46
1.75
2.20
3.54

1.07
28.15
6.88
30.94
14.74
24.76

0.l86
7.03
2.26
3.91
2.50
5.12

124.63
110.02
67.33
49.36
35.46
31.19

1.42
1.33
1.21
0.89
0.75
0.71

1.14, 1.69
1.05, 1.60
0.89, 1.52
0.63, 1.15
0.49, 1.01
0.45, 0.96

Note. NP 5 Neuropsychologically. FDS 5 Functional Deficit Score. MMT–R 5 Medication
Management Test–Revised. N 5 168 for NP-normal, N 5 99 for NP-impaired, except MMT–R,
where N 5 116 for NP-normal and N 5 77 for NP-impaired.
*Higher FDS scores represent more severe global functional impairment.
**All ps , .0001.

the NP-normal group, there were no significant differences
in FDS failure rates associated with demographic or diseaserelated variables [e.g., ethnicity: x 2 (1) 5 2.4; sex: x 2 (1) 5
0.6; age: t(166) 5 21.6; education: t(166) 5 1.5; CD4
count: t(166) 5 20.9; ps . .1 in all instances]. A similar
pattern was observed within the NP-impaired group except
that there was a greater percentage of non-White participants showing FDS failure [x 2 (1) 5 11.1, p , .001]. Analysis of failure rates within the NP-impaired group on specific
functional tests revealed a significant difference between
White and non-White participants only on the Work Assessment [x 2 (1) 5 13.6, p , .001]. On this assessment, the
NP-impaired White participants obtained higher scores than
non-White participants [t(97) 5 22.9, p , .01], but White
participants also obtained higher scores on estimates of premorbid work functioning based on the COMPASS software
analyses of work histories [t(96) 5 22.4, p , .02]. When a
difference score was calculated between current and pre-

morbid work ability scores, there was no significant difference between White and non-White participants [t(96) 5
20.5, p . .5], suggesting that the decline from premorbid
functioning was comparable for both White and non-White
participants.
Next we conducted a series of nominal logistic regressions to determine which NP abilities seemed most important in determining success or failure on the functional
measures. Using scores on the seven NP domains as potential predictors, significant ( p , .0001) omnibus models
were found for the criterion impairments on the FDS
[x 2 (7) 5 151.51, R 2 5 .44], Work Assessment [x 2 (7) 5
135.42, R 2 5 .41], Medication Management [x 2 (7) 5 59.55,
R 2 5 .25], Finances [x 2 (7) 5 73.24, R 2 5 .22], Cooking
[x 2 (7) 5 41.37, R 2 5 .14], and Shopping [x 2 (7) 5 26.96,
R 2 5 .11]. Only four NP ability areas were identified as
uniquely contributing to the prediction of impairment on
two or more of the functional measures: Abstraction 0

Fig. 1. Rate of functional impairment by neuropsychological status.
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Executive Functioning predicted failures on the FDS, Work
Assessment, Finances and Medication Management; Learning predicted failures on Medication Management, Shopping and Cooking; and Verbal function and Attention 0
Working Memory each significantly predicted failure on
the FDS and Work Assessment.
Two work profiles were generated for each participant
based upon (1) current vocational functioning using the standardized work samples (i.e., Work Assessment Total Score)
and (2) estimated maximum level of prior functioning
using standard analyses of work histories. As noted above
(Table 5), NP-impaired participants performed significantly worse than those who were NP-normal on the Work
Assessment ( p , .0001). A Pearson correlational analysis
also indicated that NP global functioning (i.e., the global
clinical NP rating) was strongly associated with the Work
Assessment Total Score (r 5 2.65, p , .0001). Participants’ estimated previous levels of vocational functioning
(based upon scores derived from work histories) were then
evaluated based on NP status. Results of a one-way ANOVA
suggested that the NP-impaired group had lower baseline
levels of vocational functioning compared to their NPnormal counterparts [M 5 37.94, SD 5 6.08, vs. M 5 40.71,
SD 5 5.62; F(1,263) 5 14.04, p , .001]. Therefore, the
discrepancies between participants’ expected (estimated
prior) levels of functioning and currently observed levels
(based upon the Work Assessment Total Score) were analyzed. A negative discrepancy score suggests that participants’ vocational functioning is worse at the time of
assessment than it has been in the past. The results of a
one-way ANOVA demonstrated that the mean discrepancy
between expected versus current level of vocational functioning was significantly greater for the NP-impaired group
compared to the NP-normal group [M 5 29.69, SD 5 7.75,
vs. M 5 23.90, SD 5 7.71; F(1,263) 5 34.50, p , .0001].

Manifest Functioning in Everyday Life
A series of bivariate analyses showed that both the FDS and
NP status (global clinical rating) were significantly related
to measures of reported everyday functioning, including
complaints of cognitive difficulties (PAOFI), degree of independence in completing IADLs at home, and employment status. Of greater interest, however, is whether FDS
and NP status make unique contributions to such predictions, when effects of biological markers of disease progression (AIDS status and CD4 count) and depression (Beck
Depression Inventory) are also considered. Therefore, we
performed multivariate analyses to address these questions.

Cognitive complaints
Table 6 summarizes a linear multiple regression analysis, in
which the criterion of interest was cognitive complaints
(PAOFI Total). The model was significant, and accounted
for approximately 38% of the variance in participants’ cognitive complaints [R 2 5 .38, F(5,235) 5 28.73, p , .0001].
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Table 6. Linear multiple regression model predicting
participants’ cognitive complaints (Patient’s Assessment
of Own Functioning Inventory Total Score) by
neuropsychological (NP) status, Functional Deficit
Score, AIDS status, immunosuppression,
and Beck Depression Inventory
Criterion
variable
PAOFI

Predictor variable

Beta
coefficient

p

Global NP Clinical Rating
Functional Deficit Score
AIDS Status
CD4 Count
BDI Total

.09
.28
.03
.03
.46

.18
,.0001
.61
.66
,.0001

Note. N 5 241. PFI 5 Patient’s Own Assessment of Functioning. BDI 5
Beck Depression Inventory.

Global functional impairment (FDS) and depressive symptomatology each significantly and uniquely contributed to
the model, while NP functioning and biological markers
(CD4 and AIDS status) did not. Post-hoc Pearson correlations revealed that higher levels of functional impairment
and depression were associated with a high number of cognitive complaints (respectively, r 5 .38, and r 5 .48, ps ,
.0001). Of note, the BDI Total Score and FDS were not
significantly associated with each other (r 5 .10, p . .05).

IADL dependence
Based on 251 participants’ patterns of responses on the IADL
questionnaire, 209 (83.3%) of them were deemed IADLindependent and 42 met criteria for IADL-dependence (criteria reviewed in the Methods section). The independent
group reported dependence on an average of only 0.38 (SD 5
0.68) of the 13 IADL tasks; by contrast, the dependent participants reported less independence in an average of 5.02
(SD 5 3.53) IADL activities. IADL-dependent participants
reported the highest rates of dependence in the areas of
Home Repair, Laundry, Grocery Shopping, Comprehension
of Reading0TV material, Shopping, and Cooking. Chisquare analyses revealed that the IADL-dependent participants required significantly more assistance in all domains
of activities of daily living (all ps , .0001) compared to
IADL-independent participants, and all comparisons remained statistically significant following Bonferroni correction ( p 5 .004).
Table 7 presents the results of a nominal logistic regression analysis, in which we input the same list of diseaserelated, depression and performance-based variables in an
effort to predict IADL status (independence vs. dependence). Again the model was significant [R 2 5 .24; x 2 (5) 5
54.23, p , .0001]. Three variables provided significant,
unique contributions to the prediction model: NP performance, the FDS and depressed mood. Post-hoc t tests revealed that, compared to IADL independent participants,
those who were dependent had significantly higher (worse)

326

R.K. Heaton et al.

Table 7. Nominal logistic regression model predicting IADL
dependence by neuropsychological (NP) status, Functional
Deficit Score, AIDS status, immunosuppression and
depressive symptoms
Criterion
variable
IADL
Dependence

Predictor variable

x2

p

Global NP Clinical Rating
Functional Deficit Score
AIDS Status
CD4 Count
BDI Total

5.01
4.67
0.37
0.14
25.63

.03
.03
.5
.71
,.0001

Note. IADL 5 Instrumental Activities of Daily Living. BDI 5 Beck Depression Inventory. N 5 250.

global NP ratings [M 5 4.81, SD 5 1.09, vs. M 5 3.63,
SD 5 1.48; t(249) 5 24.90, p , .0001], worse FDS scores
[M 5 0.94, SD 5 0.85, vs. M 5 0.41, SD 5 0.64; t(249) 5
24.57, p , .0001], and higher BDI total scores [M 5 17.55,
SD 5 10.36, vs. M 5 8.46, SD 5 7.53; t(248) 5 26.67,
p , .0001]. Table 8 presents the rates of impairment on
laboratory-based functional measures for the IADL dependent and independent groups. Chi-square analyses indicate
that the IADL-dependent group showed higher impairment
rates on all functional measures except shopping.
Because both NP functioning and FDS were significant
predictors of IADL dependence status, additional analyses
were performed to illustrate how the two laboratory-based
measures might be used together in clinical decision making. Figure 2 presents the results of an ROC curve analysis
in which FDS values were used to evaluate the likelihood
of IADL dependence; the results were statistically significant (AUC 5 0.73, SE 5 0.04, p , .0001; CI 5 0.65, 0.81).
Table 9 summarizes the utility of various FDS cut-points
in predicting IADL dependence. For demonstration purposes we chose a cut-point of 0.45 (very close to the cutpoint used to define FDS “impairment”) as providing a
reasonable balance between sensitivity (.64) and specificity
(.71). Similar analyses were performed using the NP global

Table 8. Comparison of IADL-dependent and
IADL-independent groups on percent impaired
on functional measures

Test
Work Assessment
MMT–R
Finances
Shopping
Cooking
Functional Deficit Score

IADLIADLindependent dependent x 2
24
26
26
13
19
29

60
44
43
21
48
64

p

18.9 ,.0001
3.8 .05
4.7 .03
1.7 .20
14.5 .0001
18.6 ,.0001

Note. IADL 5 Instrumental Activities of Daily Living. MMT–R 5 Medication Management Test–Revised. N 5 209 for ADL-independent, N 5 42
for ADL-dependent.

Fig. 2. ROC Curve: Global functional impairment (FDS) predicting presence or absence of IADL dependence.

ratings as predictors; although not shown here, the ROC
analysis was again highly significant (AUC 5 0.73, SE 5
.04, p , .0001; CI 5 0.66, 0.80), and a cut-point of .4 (the
definition of NP impairment) provided optimal sensitivity
(.64) versus specificity (.70).

Table 9. Diagnostic characteristics of Functional Deficit Score
(FDS) cut-scores for prediction of Independent Activities
of Daily Living (IADL) dependence
FDS cut-score

Sensitivity

Specificity

Likelihood Ratio

0.10
0.23
0.33
0.45
0.55
0.68
0.78
0.90
1.10
1.23
1.33
1.45
1.55
1.70
1.90
2.10
2.23
2.78
2.90
3.20
4.40

.88
.71
.69
.64
.57
.50
.50
.45
.36
.31
.26
.24
.21
.17
.142
.10
.07
.07
.024
.024
.000

.50
.61
.67
.71
.73
.77
.78
.84
.85
.86
.90
.91
.92
.95
.96
.97
.97
.99
.99
.99
—

1.75
1.82
2.06
2.24
2.09
2.14
2.27
2.77
2.41
2.70
2.62
2.77
2.78
3.15
3.76
3.28
2.45
7.10
2.40
4.80
—
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Figure 3 shows that, of the 134 participants who scored
below the proposed cutoffs (i.e., performed normally) on
both the FDS and NP global rating, only 5.2% were dependent in their IADLs. By contrast, impairment on either predictor (NP or functional) was associated with greater than a
5-fold increase in the likelihood of dependence. Note that
the 58 participants who were impaired on just one of the
performance-based predictors would be much more likely
to be misclassified if only the other (NP or functional) battery had been used alone.

Table 10. Nominal logistic regression model predicting
employment by measures by neuropsychological (NP) status,
Functional Deficit Score, AIDS status, immunosuppression,
and depressive symptoms

Employment status

Note. BDI 5 Beck Depression Inventory. N 5 257.

Lastly, employment status was evaluated. A chi-square analysis revealed that the NP-impaired group was significantly
more likely to be unemployed compared to their NPnormal counterparts [88% vs. 63%; x2 (1) 5 21.0, p , .0001].
Table 10 shows the results of a nominal logistic regression
analysis to predict employment status (employed vs. unemployed ), again using the two performance-based measures (NP and FDS status), depression, and measures of
disease progression as the independent variables. The model
was significant [R 2 5 .24, x 2 (5) 5 72.31, p , .0001], and
three measures contributed uniquely: FDS, AIDS status and
depressed mood. Follow-up analyses revealed that, compared to their employed counterparts, unemployed participants were more likely to have AIDS [65% vs. 42%; x 2 (1) 5
11.12, p , .001], as well as higher levels of global functional impairment [FDS; t(256) 5 23.89, p , .0001] and
depression [BDI Total; t(255) 5 25.77, p , .0001].

DISCUSSION
This study supports and extends previous reports regarding
the everyday life significance of NP impairments associated with HIV infection (Albert et al., 1995; Heaton et al.,
1996; Hinkin et al., 2002; Marcotte et al., 1999; Stern et al.,
1991). It is the largest such study to date and the most
comprehensive in its coverage of both performance-based
measures of IADLs and manifest measures of daily functioning outside of the laboratory. The laboratory measures

Criterion variable
Employment

Predictor variable

x2

p

Global NP Clinical Rating
Functional Deficit Score
AIDS Status
CD4 Count
BDI Total

0.60
6.30
8.94
1.27
22.32

.44
.01
,.01
.26
,.0001

cover a variety of tasks relevant to everyday living, ranging
from relatively basic skills (shopping and cooking) to more
demanding activities (vocational functioning).
The newer laboratory-based measures of IADLs introduced here were found to have adequate internal consistency reliability (Table 5). Moderate ceiling effects were
expected on these measures, especially since the majority
of our participants were NP-normal, but participants who
did have NP impairment evidenced a range of IADL performance problems. Thus, the functional battery was able
to demonstrate excellent concurrent validity with NP testing: NP impairment was associated with much higher rates
of failure on each of the laboratory based functional measures (Figure 1).
It is unlikely that demographic variables, rather than HIV
infection, explained impaired performance on tests of everyday functioning. FDS was not significantly associated
with age, gender, or ethnicity among the NP-normal group.
Similar findings were obtained in the NP-impaired group
with respect to age, gender, and education. Although nonWhite participants in this group were more likely to be
impaired on the Vocational Assessment (but not other functional measures), this appeared to be due to lower premorbid vocational functioning rather than acquired functional
impairment. That is, according to COMPASS analysis of
work histories, they demonstrated lower levels of pre-

Fig. 3. Rate of IADL dependence by neuropsychological and functional impairment status.
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morbid vocational functioning. When this difference was
controlled, the ethnicity effect on current vocational functioning was not significant.
Most of our participants had reported significant current
and0or past everyday experience with the types of tasks
measured here (i.e., checkbook balancing, cooking). Thus,
the high rate of impairment on tests of everyday functioning among the NP-impaired participants probably cannot
be explained on the basis of lack of relevant experience.
The question of which NP abilities are essential for specific everyday tasks is interesting and potentially important
in clinical decision-making. In general, if a person shows
NP impairment on tests of a certain ability, he0she would
be considered at risk for failure in everyday tasks that require the same ability (Heaton & Pendleton, 1981). Perhaps
not surprisingly, we found that the NP deficits which best
predicted failures on standardized tests of IADLs, were those
that also are most commonly observed among cognitively
impaired HIV1 participants. Specifically, problems with
Learning, Abstraction0Executive Function, and Attention0
Working Memory, which would be consistent with involvement of frontostriatal brain systems, accounted for most of
the unique variance in predictions of individual IADL failures and failure on the total functional battery (FDS). Although it makes sense that, for example, learning deficits
uniquely contribute to the prediction of problems with medication management, shopping and cooking, it is important
to recognize that learning deficits rarely occur in isolation
within the HIV infected population. Also, IADLs themselves involve multiple cognitive abilities, and may be failed
equally by people who have different patterns of NP deficits. Nevertheless, our results suggest that impairments in
the above three ability domains are particularly likely to be
associated with problems in everyday functioning of HIV
infected adults.
Our measures of manifest everyday functioning ranged
from subjective experience of cognitive difficulties (PAOFI),
to presumably less subjective reports of how independently
IADLs are actually being performed, and still more objectively observable employment status. NP testing still predicts employment status when included in a model alone,
but is not significant when functional measures are added
(Table 10). However, performance on the functional battery (FDS) uniquely contributed to the prediction of all
three of these manifest indicators of everyday functioning,
even when NP testing and measures of HIV disease progression were also being considered in the multivariate prediction models. This suggests that performance based
functional measures of the sorts used in our study may compliment NP testing in determining whether HIV infected
persons suffer from “syndromic” neurocognitive conditions such as minor cognitive–motor disorder.
Figure 3 illustrates the finding that impairment on either
NP testing or functional testing (or both) is associated with
a substantial (51 fold) increase in risk for IADL dependence. It must be acknowledged, however, that more than
half of our participants who were impaired on standardized
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ability testing claimed to be fully independent in their IADLs.
One likely reason for this is that our total participant sample is relatively healthy (e.g., all were ambulatory and only
one-third had even a history of an AIDS defining illness),
and only 37% evidenced any kind of NP impairment. The
associated very low prevalence of IADL dependence in this
sample (16.7%) makes for a challenging prediction problem, whereas in populations having higher base rates of
dependence the positive predictive value of results on standardized ability tests will ostensibly improve (Baldessarini
et al., 1983). In fact, higher rates of dependence would be
expected in other HIV1 groups, such as those with more
advanced illness and among clinical referrals with specific
concerns about IADL dependence.
Of particular importance for HIV infected persons is their
ability to manage complex medication regimens: Although
the availability of powerful new drug combinations (highly
active antiretroviral treatments) offers the potential to extend both the duration and quality of life, they require the
patient to understand and follow detailed instructions about
the proper timing and dosage of multiple drug administrations throughout each day. Our revision of the Medication
Management Test (Albert et al., 1999) was designed to efficiently tap these abilities. As expected, NP impairment
was associated with poor performance on laboratory-based
measures of IADLs, including medication management.
However, a limitation of the current study is that it did not
include a measure of participants’ accuracy in following
their own antiretroviral medication regimens. For example,
Hinkin et al. (2002) have used electronic monitoring technology (MEMS caps) to track medication use in HIV infected adults, and found that those who were NP-impaired
evidenced worse adherence to their prescribed regimens.
Future research with laboratory based medication management tasks should seek to validate them using MEMS caps
or other objective methods of assessing adherence.
Because this is a cross sectional study, our prediction
models are strictly correlational and are unable to prove
cause–effect relationships. Nevertheless, it makes sense that
impairments demonstrated on laboratory based tests of impairments in NP and functional abilities are likely to cause
affected individuals to experience difficulties in their everyday functioning. This is especially true for standardized
tasks that were designed to mimic essential activities of
daily living. On the other hand, the causal significance of
depressed mood in our prediction models of manifest everyday functioning is open to question: For example, depressed mood might contribute to disability, or depression
might only bias (negatively) participants’ perceptions and
reports of their everyday functioning. There are two reasons to suspect that depression is indeed a source of disability in this population. The first is the fact that the BDI total
score made very significant contributions to the prediction
of both subjective and objective indicators of everyday functioning in this study, whereas biased perceptions would be
most likely to influence subjective experiences (i.e., the
PAOFI; Chelune et al., 1986). Second, the BDI contribution
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to prediction of manifest functioning was independent of
NP and functional test performances. This suggests that
some HIV1 participants had the basic abilities to function
at higher levels, but may have failed to do so because of
their affective status. If future research confirms this possibility, there may be substantial benefits for early detection
and treatment of depressive symptoms. As part of this process, objective NP and functional tests such as those employed here may help identify patients who have the potential
for more independent, productive living.
In addition to possible effects of depression, there may
be other reasons why people with CNS disorders fail to
perform IADLs as well as their basic abilities would allow.
For example, those with adequate abilities to follow a complex medication regimen may fail to do so consistently because of temporary interference from substance use disorders
(Hinkin et al., 2004), or even inadequate motivation due to
failure to believe that carefully following prescribed methods will actually make a difference. Future research should
identify how often failures to accurately follow prescribed
medication regimens are due to ability problems versus these
other factors, because potentially effective interventions are
likely to be different.
In addition to their apparent utility in predicting concurrent everyday functioning, laboratory based functional tests
may be useful in measuring clinically significant change in
neurobehavioral disorders. For example, such tests could
be used as ecologically relevant outcome measures in future clinical trials of medications that may improve the disorders; for HIV related disorders these might include new
antiretrovirals or putative neuroprotectants such as memantine or selegiline. However, for these purposes additional
information is needed about how the tests perform in a
longitudinal context. Future research must establish testretest reliability, provide estimates of practice effects, and
develop normative guidelines for determining when a testretest difference is greater than expected in the absence of
meaningful change in the patient (Temkin et al., 1999).
In summary, the present findings confirm the importance
of assessing NP status in the prediction of everyday functional ability both in the laboratory and in real life, and
suggest that HIV-related NP impairments consistent with
frontostriatal involvement, in particular, are strongly predictive of functional impairment. In addition, measures of
depression and laboratory-based measures of functional ability appear to be key predictors of real-life functioning, such
that clinicians’ and researchers’ appreciation of patients’
problems in everyday functioning may indeed be incomplete without such additional information. Future research
is needed in order to further investigate the role of depression in functional morbidity of HIV infected persons, evaluate the use of these new functional technologies in other
patient populations such as traumatic brain injury, assess
their usefulness in measuring ecologically significant change
in neurobehavioral status, and extend our understanding of
the real-world implications of NP impairments on other important aspects of everyday functioning.
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Appendix
tLOPEROL CAPSULES
COMPOSITION:
2 mg loperamide hydrochloride per capsule.

Adults:
Two capsules initially, followed by one capsule after each
loose stool. The usual dosage is 3 to 4 capsules a day.
The maximum daily dose should not exceed 8 capsules.

INDICATIONS:
Symptomatic treatment of acute diarrhea.

Children 9 to 12 years:
One capsule four times daily until diarrhea is controlled.

CONTRA-INDICATIONS:
• Known sensitivity to loperamide.
• Safety in pregnancy and lactation has not been established.
• LOPEROL must not be used when inhibition of peristalsis is to be avoided, in particular where constipation is
present or in patients with inflammatory bowel disease.
Discontinue use immediately if constipation or abdominal distension develop.
WARNINGS:
• Patients with inflammatory bowel disease receiving loperamide should be carefully observed for signs of toxic
megacolon.
• Keep out of reach of children.
• If no improvement in acute diarrhea has been observed
after 48 hours, LOPEROL should be discontinued.

SIDE-EFFECTS AND SPECIAL PRECAUTIONS:
Abdominal cramps and bloating as well as skin reactions
have been reported. Dry mouth, dizziness and fatigue may
occur.
KNOWN SYMPTOMS OF OVERDOSAGE AND
PARTICULARS OF ITS TREATMENT:
Overdosage may lead to constipation and depression of the
central nervous system. Children may be more sensitive to
central nervous system depressant effects of loperamide than
adults. Convulsions have been reported in children under
the age of 2 years.
STORAGE INSTRUCTIONS:
Keep well closed and store in a dry place below 258C.
Keep out of reach of children.
tRegistered Trademark

DOSAGE AND DIRECTIONS FOR USE:
This product is not intended for use in children under the
age of 9 years.
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